‘We are a savings platform, not a Quick-commerce player’: Rahul Guha
After a turbulent period of leadership churn and persistent losses, API Holdings, the parent of Pharmeasy, Thyrocare and medicine distributor Ascent, is focused on stitching all its business segments into a single, profitable OPD healthcare platform. Heading this turnaround is Rahul Guha, who formally took over as MD and CEO last August, and aims to turn the company profitable by March next year. In an interview with Ayanti Bera, Guha outlines the company’s path to profits, Thyrocare’s next phase of growth in specialised diagnostics, and focus on deleveraging the balance sheet ahead of a potential market listing. Excerpts:
